Mission3, the premier Regulatory Information Management software provider for the Life Sciences industry, today announced the general availability of the Clireo 4.0, Mission3’s cloud-based electronic document, project, and submission management solution with new features and delivery on Microsoft Azure. Additionally, Mission3 has entered into an enterprise agreement with Microsoft in order to provide an HIPAA qualified platform through a Business Associates Agreement (BAA).Continue reading
Author Archive: AZBio
HTG Edge System Wins 2013 Silver Medical Design Excellence Award
The Edge System, developed and commercialized by HTG Molecular Diagnostics, is the 2013 Silver Award recipient for in-Vitro Diagnostics in the 15th Annual Medical Design Excellence Awards competition.Continue reading
ASU Startup Viomics Wins $250,000 in Funding from Arizona Commerce Authority
Molecular diagnostics company is awarded $250,000 to continue development of cancer detection technologiesContinue reading
Flagship Biosciences develops quantitative pathology analysis of fibrosis
Presentation at the Society for Toxicologic Pathology demonstrates the ability to quantify fibrosis in nonalcoholic steatohepatitisContinue reading
Save 10% on AdvaMed 2013
Achieve Your Business Goals and Drive Industry Conversation at AdvaMed 2013: The MedTech Conference Continue reading
$6M Grant Boosts Molecular Heart Research
Combining the resources and expertise of seven institutions in North America and Europe, the research program will offer insights into the molecular workings of heart muscle cells and how genetic mutations affect their function.Continue reading
It’s Not Always Easy To Do What’s Right
A guest post by Representative Heather Carter, Chair of the Health and Human Services Committee, Arizona House of Representatives.Continue reading
MSDx, Inc. Awarded a Rapid Response Innovation Grant
MSDx, Inc. Awarded a Rapid Response Innovation Grant from The Michael J. Fox Foundation For the Development of Biomarkers in Parkinson’s DiseaseContinue reading
BIO Statement On U.S. Supreme Court Review Of Isolated DNA Patents
Washington, D.C. (June 13, 2013)
Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on the U.S. Supreme Court’s decision regarding Myriad Genetics’ patent claims on isolated DNA molecules: Continue reading
MSDx seeks USD 5m first VC round for blood-based multiple sclerosis monitoring assay, CEO says
BioPharm Insight Profiles MSDxContinue reading